Position in HALO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$474,319
+$115,005 QoQ
Shares Held
7,339
+37.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026INGALLS & SNYDER LLC holds $352,579,823 across 11 Biotechnology names. HALO ranks #7 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
7,608,716 | $306,707,341 | |
| 2 | OMER |
Omeros Corp
|
3,559,423 | $37,587,506 | |
| 3 | HYFT |
MindWalk Holdings Corp.
|
2,907,040 | $3,284,955 | |
| 4 | GMAB |
Genmab A/S
|
72,891 | $1,955,665 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,012 | $1,344,978 | |
| 6 | EPRX |
Eupraxia Pharmaceuticals Inc.
|
75,650 | $547,706 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
This page
|
7,339 | $474,319 | |
| 8 | VCEL |
Vericel Corp
|
14,200 | $456,814 |
All Filings in HALO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $474,319 | 7,339 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $359,314 | 5,339 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $396,916 | 5,412 | Shares | Other | 2025-11-07 | |
| 2020-12-31 | $349,367 | 8,180 | Shares | Other | 2021-01-27 | |
| 2020-09-30 | $332,573 | 12,655 | Shares | Other | 2020-10-21 | |
| 2020-06-30 | $339,280 | 12,655 | Shares | Other | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||